Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Glimm
Specific Elimination of CD133+ Tumor Cells With Targeted Oncolytic Measles Virus
Cancer Research
Cancer Research
Oncology
Related publications
Oncolytic Measles Virus Therapy Enhances Tumor Antigen-Specific T-Cell Responses in Patients With Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus
Cancer Research
Cancer Research
Oncology
Chemovirotherapy for Head and Neck Squamous Cell Carcinoma With EGFR-targeted and CD/UPRT-armed Oncolytic Measles Virus
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted Against the Urokinase Receptor
Cancer Research
Cancer Research
Oncology
639. MicroRNA-Mediated Multi-Tissue-Detargeting of Oncolytic Measles Virus
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
642. Pre-Existing Antiviral State Can Impact Oncolytic Infection in Glioblastoma Patients Treated With Oncolytic Measles Virus
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Development of an Oncolytic Herpes Simplex Virus Using a Tumor-Specific HIF-responsive Promoter
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Dynamics of Multiple Myeloma Tumor Therapy With a Recombinant Measles Virus
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Treatment of Breast Cancer Stem Cells With Oncolytic Herpes Simplex Virus
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
